| Line item | 2025-12-31 FY | 2025-12-12 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | $0.00 | $1.33M | $1.26M | $1.20M | $1.39M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | $272.73K | $414.52K |
| Operating Expenses | – | – | $1.07M | $1.02M | $9.07M | $9.25M |
| R&D | – | – | $0.00 | $109.62K | $731.33K | $1.03M |
| SG&A | – | – | – | – | – | – |
| Operating Income | -$7.59M | – | -$4.93M | -$15.75M | -$8.79M | -$8.83M |
| Interest Expense | – | – | $42.45K | $31.16K | $176.00K | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$18.26M | $94.45K | -$7.90M | -$16.71M | -$11.93M | -$9.09M |
| EPS (basic) | -5.6400 | – | -8.4400 | -1.5900 | -1.2800 | -1.0700 |
| EPS (diluted) | -5.6400 | – | -8.4400 | -1.5900 | -1.2800 | -1.0700 |
| Shares (diluted) | $3.21M | – | $936.61K | $10.53M | $9.33M | $8.49M |